These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9691142)
1. Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia. Watanabe I; Horiuchi T; Hatta N; Matsumoto M; Koike K; Kojima S; Ohga S; Fujita S Acta Haematol; 1998; 100(1):22-5. PubMed ID: 9691142 [TBL] [Abstract][Full Text] [Related]
2. p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1. Luria D; Avigad S; Cohen IJ; Stark B; Weitz R; Zaizov R Cancer; 1997 Nov; 80(10):2013-8. PubMed ID: 9366306 [TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia. Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of NF1 gene in juvenile chronic myelogenous leukemia with neurofibromatosis type 1. Kai S; Sumita H; Fujioka K; Takahashi H; Hanzawa N; Funabiki T; Ikuta K; Sasaki H Int J Hematol; 1998 Jul; 68(1):53-60. PubMed ID: 9713168 [TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia. Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976 [TBL] [Abstract][Full Text] [Related]
6. Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras. Kalra R; Paderanga DC; Olson K; Shannon KM Blood; 1994 Nov; 84(10):3435-9. PubMed ID: 7949098 [TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
9. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751 [TBL] [Abstract][Full Text] [Related]
10. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Miyauchi J; Asada M; Sasaki M; Tsunematsu Y; Kojima S; Mizutani S Blood; 1994 Apr; 83(8):2248-54. PubMed ID: 8161790 [TBL] [Abstract][Full Text] [Related]
11. Homozygosity at variant MLH1 can lead to secondary mutation in NF1, neurofibromatosis type I and early onset leukemia. Alotaibi H; Ricciardone MD; Ozturk M Mutat Res; 2008 Jan; 637(1-2):209-14. PubMed ID: 17889038 [TBL] [Abstract][Full Text] [Related]
12. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Zvulunov A; Barak Y; Metzker A Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061 [TBL] [Abstract][Full Text] [Related]
13. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia. Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676 [TBL] [Abstract][Full Text] [Related]
14. Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Miles DK; Freedman MH; Stephens K; Pallavicini M; Sievers EL; Weaver M; Grunberger T; Thompson P; Shannon KM Blood; 1996 Dec; 88(11):4314-20. PubMed ID: 8943868 [TBL] [Abstract][Full Text] [Related]
15. [Hereditary hematopoietic malignancy with emphasis of juvenile chronic myelogenous leukemia and 7 monosomy syndrome]. Hayashi Y Nihon Rinsho; 1995 Nov; 53(11):2737-41. PubMed ID: 8538036 [TBL] [Abstract][Full Text] [Related]
16. Juvenile chronic myelogenous leukemia, neurofibromatosis 1, and xanthoma. Jang KA; Choi JH; Sung KJ; Moon KC; Koh JK; Im DJ J Dermatol; 1999 Jan; 26(1):33-5. PubMed ID: 10063210 [TBL] [Abstract][Full Text] [Related]
17. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167 [TBL] [Abstract][Full Text] [Related]
18. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. Shannon KM; O'Connell P; Martin GA; Paderanga D; Olson K; Dinndorf P; McCormick F N Engl J Med; 1994 Mar; 330(9):597-601. PubMed ID: 8302341 [TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression. Kaneko H; Horiike S; Nakai H; Ueda Y; Nakao M; Hirakawa K; Yokota S; Taniwaki M; Misawa S; Kashima K Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322 [TBL] [Abstract][Full Text] [Related]
20. Monosomy 7 myeloproliferative disease associated with neurofibromatosis type I: a case report. Savasan S; Zülfikar B; Ozgeneci A; Ozbek U; Sengün Z J Chemother; 1996 Jun; 8(3):243-6. PubMed ID: 8808725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]